Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 18 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hormones Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Castration Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1996 2022

Research Output 1985 2017

  • 11851 Citations
  • 42 Scopus h-Index
  • 106 Article
  • 14 Review article
  • 5 Comment/debate

Academic cancer center phase i program development

Frankel, A. E., Flaherty, K. T., Weiner, G. J., Chen, R., Azad, N. S., Pishvaian, M. J., Thompson, J. A., Taylor, M. H., Mahadevan, D., Lockhart, A. C., Vaishampayan, U. N., Berlin, J. D., Smith, D. C., Sarantopoulos, J., Riese, M., Saleh, M. N., Ahn, C. & Frenkel, E. P. Apr 1 2017 In : Oncologist. 22, 4, p. 369-374 6 p.

Research output: Contribution to journalComment/debate

Biomedical Research
Clinical Trials
6 Citations

Phase I, dose-escalation, two-part trial of the PARP inhibitor talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers

de Bono, J., Ramanathan, R. K., Mina, L., Chugh, R., Glaspy, J., Rafii, S., Kaye, S., Sachdev, J., Heymach, J., Smith, D. C., Henshaw, J. W., Herriott, A., Patterson, M., Curtin, N. J., Byers, L. A. & Wainberg, Z. A. 2017 In : Cancer Discovery. 7, 6, p. 620-629 10 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Antineoplastic Agents
Ovarian Neoplasms

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy

Jackson, W. C., Feng, F. Y., Daignault, S., Hussain, M., Smith, D., Cooney, K., Pienta, K., Jolly, S., Hollenbeck, B., Olson, K. B., Sandler, H. M., Ray, M. E. & Hamstra, D. A. Jan 1 2016 In : Advances in Radiation Oncology. 1, 1, p. 59-66 8 p.

Research output: Contribution to journalArticle

Salvage Therapy
Prostate-Specific Antigen

Electrocardiographic characterization of ramucirumab on the corrected qt interval in a phase ii study of patients with advanced solid tumors

Olszanski, A. J., Smith, D. C., Camacho, L. H., Thompson, J., Ramalingam, S. S., Donald Harvey, R., Campos, L., Ferry, D., Tang, S., Gao, L. & Safran, H. Apr 1 2016 In : Oncologist. 21, 4, p. 402-403 2 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor-2
Least-Squares Analysis
Non-Small Cell Lung Carcinoma
1 Citations

Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors

Smith, D. C., Powderly, J., Lee, J. J., Shepard, D. R., Wallin, J., Chaudhary, A., Chao, G. Y., Ng, W. T., Mitchell, M. I., Grau, G., Kurek, R. & LoRusso, P. Aug 1 2016 In : Cancer Chemotherapy and Pharmacology. 78, 2, p. 271-280 10 p.

Research output: Contribution to journalArticle

Carbocyclic Acids
Contraception Behavior
Butylene Glycols